Top Intraocular Lens Companies in 2025| Renub Research

An intraocular lens (IOL) is a synthetic lens placed inside the eye to substitute for the natural lens of the eye when it is extracted in cataract surgery or to fix refractive defects. IOLs are usually constructed of biocompatible materials like silicone or acrylic and are intended to be permanent inside the eye. The lenses restore vision by refracting light appropriately onto the retina, thus improving clarity and diminishing reliance on eyeglasses or contact lenses.

Worldwide, IOLs are utilized most frequently to manage cataracts—one of the most prevalent forms of blindness—primarily in elderly groups. Besides traditional monofocal IOLs, newer models such as multifocal, toric, and accommodating lenses provide better vision at different distances or eliminate astigmatism.

The growing aging population, technological innovations in ophthalmic devices, and increasing eye health awareness are fueling the global demand for IOLs. They are an integral part of contemporary vision correction and eye care globally. The intraocular lens market is expected to reach US$ 4.46 billion in 2024 and is expected to expand to US$ 7.16 billion by 2033, registering a compound annual growth rate (CAGR) of 5.40% during 2025-2033.